Park Seung Ha, Jeon Woo Kyu, Kim Sang Hoon, Kim Hong Joo, Park Dong Il, Cho Yong Kyun, Sung In Kyung, Sohn Chong Il, Kim Byung Ik, Keum Dong Keuk
Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Natl Med Assoc. 2005 Apr;97(4):508-13.
An increased risk in coronary heart disease associated with Helicobacter pylori (H. pylon) appears to be partially mediated by modifications of the atherogenic lipoprotein and inflammatory parameters. We conducted a controlled trial aimed at evaluating the changes of metabolic and inflammatory parameters after H. pylon eradication.
We included in the study 169 patients with H. pylori infection and conducted a retrospective longitudinal survey of 87 subjects (76 men, 11 women) who received treatment for H. pylon eradication and 82 control subjects (63 men, 19 women) who did not receive treatment. We compared pre- and posteradication (one year after) the metabolic and inflammatory parameters, such as blood sugar, lipid profiles, insulin resistance, white blood cell count and C-reactive protein.
No significant changes from the baseline in metabolic and inflammatory parameters within each group were observed. Changes in the serum levels of metabolic and inflammatory parameters were similar between the two groups.
Metabolic and inflammatory parameters, including blood sugar, lipid profiles, insulin resistance, white blood cell count and C-reactive protein, were not changed after H. pylori eradication treatment. H. pylori eradication has no effect on metabolic and inflammatory parameters.
幽门螺杆菌(H. pylori)与冠心病风险增加之间的关联似乎部分是由致动脉粥样硬化脂蛋白和炎症参数的改变介导的。我们进行了一项对照试验,旨在评估幽门螺杆菌根除后代谢和炎症参数的变化。
我们纳入了169例幽门螺杆菌感染患者,并对87例接受幽门螺杆菌根除治疗的受试者(76例男性,11例女性)和82例未接受治疗的对照受试者(63例男性,19例女性)进行了回顾性纵向调查。我们比较了根除前后(一年后)的代谢和炎症参数,如血糖、血脂谱、胰岛素抵抗、白细胞计数和C反应蛋白。
每组内代谢和炎症参数与基线相比均未观察到显著变化。两组间代谢和炎症参数的血清水平变化相似。
根除幽门螺杆菌治疗后,包括血糖、血脂谱、胰岛素抵抗、白细胞计数和C反应蛋白在内的代谢和炎症参数未发生变化。根除幽门螺杆菌对代谢和炎症参数没有影响。